OncoImmunin products are continually expanding in response to the needs of the biomedical community, whether engaged in basic or developmental research.  Many of OncoImmunin’s probes are a direct result of interactions between OncoImmunin scientists and the research community.

OncoImmunin的主要产品包括：

Patented Technologies

Apoptosis

Drug Delivery

Licensing and Screening

Cancer Metastasis

Cellular Cytotoxicity

Inflammation

Information

Viral Detection

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

GLYCON Biochemicals GmbH公司位于德国Luckenwalde，是一家专门从事特种糖类化合物研发、生产的公司，除了高品质的目录产品，GLYCON Biochemicals GmbH公司还承接定制合成生产，包括糖及其衍生物、糖复合物等，可以进行1-10kg规模的生产。

GLYCON emphasises research and development, combining innovative thinking with the necessities of the market. We offer the flexible service and modern equipment needed to produce gram and kilogram quantities of fine and pharmaceutical chemicals.

Custom synthesis and service

- carbohydrates and their derivatives

- glycoconjugates

- small scale production (1 g - 10 kg)

- chromatography on 25 L columns

主要产品类型

（1）non ionic detergents

alkyl glucopyranoside

alkyl maltoside

alkyl thio-glycosides

mega

alkylethyleneglycol

other products

（2）ionic detergents

cholesterols (chaps, chapso)

alkylphosphocholine

（3）sugar phosphates

（4）carbohydrates

更多详情请联系 

艾美捷科技有限公司

全国服务热线：400-6800-868

邮箱：sales@amyjet.com

网站：www.amyjet.com

Allele Biotechnology位于美国圣地亚哥市，主要专注于对生物过程的机制进行探索，以开发生物医学及治疗相关的技术和产品。以各个物种的iPS细胞、人类cGMP iPS细胞及衍生的细胞为材料，Allele Biotechnology利用专利性的非整合细胞编辑方法，开发了出了细胞治疗和药物筛选的技术。Allele Biotechnology具有深厚的基因组修饰和细胞荧光报告因子的经验，为客户提供优异的细胞检测解决方案。Allele Biotechnology还提供荧光蛋白、高效荧光素酶底物、基因分型试剂盒、骆驼抗体等产品；此外还在RNA干扰领域尤其独特的专利。

Allele Biotechnology and Pharmaceuticals, Inc. is a private, San Diego-based company that explores the mechanisms of biological processes to develop technologies and products for biomedical research and therapy development.

Our mission is to increase accessibility to innovative molecular biology research tools by offering cutting edge technologies in individual products and fully integrated platforms. Allele utilizes proprietary non-integrating cellular reprogramming methods to develop cell therapy and enable drug discovery through the use of human and non-human primate iPS cells, cGMP-grade human iPS cells and their derivatives. With additional expertise in genome modification and unique cell-based fluorescence sensors/reporters, Allele provides advanced cell and assay development solutions. Allele also has developed a wide variety of advanced research tools including superior fluorescent proteins, highly efficient luciferase assay substrates, genotyping kits, and camelid antibodies that have been validated for co-immunoprecipitation, histology, and flow cytometry. The Company has also been a leader in the RNAi field with its patents in Pol III promoter-driven siRNA, shRNA, and miRNA.